Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 4,010.00
-15.00 (-0.37%)
At close: Jun 10, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 92.51 billion as of June 10, 2026. Its market cap has increased by 18.29% in one year.
Market Cap
92.51B
Enterprise Value
83.35B
Revenue
26.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,010.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 92.51B, an increase of 5.26%. That is a compound annual growth rate of 0.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 92.51B | -55.39% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 259.85B |
| 3billion | 232.30B |
| GENINUS | 96.40B |
| Inventera | 88.65B |
| GC Medical Science | 75.23B |
| HLB Panagene | 62.87B |
| Protia | 52.16B |
| Seoulin Bioscience | 43.99B |